Brief: U.K. MHRA Grants Meeting To Cytodyn To Discuss Fast Track Approval Of Leronlimab For COVID-19

Cytodyn

02/09/2020 21:27

Sept 2 (Reuters) - Cytodyn Inc  CYDY.PK :
    * U.K. MHRA GRANTS MEETING TO CYTODYN TO DISCUSS FAST TRACK
APPROVAL OF LERONLIMAB FOR COVID-19 PATIENTS
    * CYTODYN INC - U.S. FDA SCHEDULES TYPE A MEETING WITH
CYTODYN TO
DISCUSS BLA FILING FOR HIV
    * CYTODYN INC - ON SUGGESTION OF MHRA, WILL SUBMIT CURRENT
PHASE 3
CD12 STUDY FOR SEVERE-TO-CRITICAL COVID-19 PATIENTS IN UK TO UPH
RESEARCH SCHEME
    * CYTODYN INC - U.K MHRA REQUESTED MEETING WITH CO ON
SEPTEMBER 9
TO DISCUSS CO'S REQUEST FOR FAST TRACK APPROVAL OF LERONLIMAB
    * CYTODYN INC - U.S. FDA HAS SCHEDULED A TYPE A MEETING ON
SEPTEMBER 8 TO DISCUSS BLA FILING FOR HIV

Source text for Eikon:  ID:nGNX7KbF02 
Further company coverage:  CYDY.PK 

 ((Reuters.Briefs@thomsonreuters.com;))